ArticleJournal of hepatocellular carcinoma2024

Efficacy and Safety of Lenvatinib Plus Programmed Death-1 Inhibitors with or Without Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma.

Ming Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.